Proteomic analysis of pulmonary tissue in tail-suspended rats under simulated weightlessness

Journal of Proteomics

Volumn 75, Issue 17, 2012, Pages 5244-5253

  Wang, Junfeng ^a   Liu, Changting ^a   Li, Tianzhi ^a   Wang, Yang ^a   Wang, Delong ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Lung injury; Proteomics; Rat; Simulated weightlessness

Indexed keywords

CYTOSKELETON PROTEIN; PEROXIREDOXIN 1; TRANSGELIN; TRANSGELIN 2; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; DOWN REGULATION; IMMUNOCYTOCHEMISTRY; ISOELECTRIC POINT; LUNG INJURY; LUNG PARENCHYMA; MALE; MASS SPECTROMETRY; METABOLISM; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEOMICS; RAT; SIGNAL TRANSDUCTION; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; WEIGHTLESSNESS; WESTERN BLOTTING;

ANIMALS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HINDLIMB SUSPENSION; LUNG; MALE; MICROFILAMENT PROTEINS; MODELS, BIOLOGICAL; MUSCLE PROTEINS; PEROXIREDOXINS; PROTEINS; PROTEOME; PROTEOMICS; RATS; RATS, SPRAGUE-DAWLEY; VALIDATION STUDIES AS TOPIC; WEIGHTLESSNESS SIMULATION;

RATTUS;

EID: 84865555646     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2012.06.007     Document Type: Article

References (58)

1. Mitchell B.M., Meck J.V. Short-duration spaceflight does not prolong QTc intervals in male astronauts. Am J Cardiol 2004, 93:1051-1052.
2. Hansen G., Martinuk K.J., Bell G.J., MacLean I.M., Martin T.P., Putman C.T. Effects of spaceflight on myosin heavy-chain content, fibre morphology and succinate dehydrogenase activity in rat diaphragm. Pflugers Arch 2004, 448:39-247.
3. Lang T., LeBlanc A., Evans H., Lu Y., Genant H., Yu A. Cortical and trabecular bone mineral loss from the spine and hip in long-duration spaceflight. J Bone Miner Res 2004, 9:1006-1012.
4. Sonnenfeld G., Butel J.S., Shearer W.T. Effects of the space flight environment on the immune system. Rev Environ Health 2003, 18:1-17.
5. Uva B.M., Masini M.A., Sturla M., Bruzzone F., Giuliani M., Tagliafierro G., et al. Microgravity induced apoptosis in cultured glial cells. Eur J Histochem 2002, 46:209-214.
6. West J.B. Microgravity and the lung. Physiologist 1991, 34:s8-s10.
7. West J.B., Elliott A.R., Guy H.J., Prisk G.K. Pulmonary function in space. JAMA 1997, 77:1957-1961.
8. Prisk G.K. Microgravity and the lung. J Appl Physiol 2000, 89:385-396.
9. Elliott A.R., Prisk G.K., Guy H.J.B., Kosonen J.M., West J.B. Forced expirations and maximum expiratory flow-volume curves during sustained microgravity on Spacelab SLS-1. J Appl Physiol 1996, 81:33-43.
10. Elliott A.R., Prisk G.K., Guy H.J.B., West J.B. Lung volumes during sustained microgravity on Spacelab SLS-1. J Appl Physiol 1994, 77:2005-2014.
11. Guy H.L.B., Prisk G.K., Elliott A.R., Deutschman R.A., West J.B. Inhomogeneity of pulmonary ventilation during sustained microgravity as determined by single-breath washouts. J Appl Physiol 1994, 76:1719-1729.
12. Prisk G.K., Guy H.J., Elliott A.R., Deutschman R.A., West J.B. Pulmonary diffusing, capacity, capillary blood volume, and cardiac output during sustained microgravity on Spacelab SLS-1. J Appl Physiol 1993, 75:15-26.
13. Prist G.K., Guy H.J.B., Elliott A.R., West J.B. Inhomogeneity of pulmonary perfusion during sustained microgravity on Spacelab SLS-1. J Appl Physiol 1994, 76:1730-1738.
14. Prisk G.K., Elliott A.R., Guy H.J.B., Kosonen J.M., West J.B. Pulmonary gas exchange and its determinants during sustained microgravity on Spacelab SLS-1 and SLS-2. J Appl Physiol 1995, 79:1290-1298.
15. Prisk G.K., Guy H.J.B., Elliott A.R., Paiva M., West J.B. Ventilatory inhomogeneity determined from multiple-breath washouts during sustained microgravity on Spacelab SLS-1. J Appl Physiol 1995, 78:597-607.
16. Junfeng W., Changting L., Xiqing S., Delong W., Changyong W., Changbin Y., et al. Effects of -6° head down tilt to simulate weightlessness on lung function. J Prev Med Chin PLA 2010, 35:1319-1321.
17. Junfeng W., Changting L., Delong W. Effects of simulated weightlessness on lung function in tail-suspended rats. J Chin PLA Postgrad Med Sch 2002, 23:290-292.
18. Grindeland R.E., Ballard R.W., Connolly J.P., Vasques M.F. COSMOS 2044 mission. J Appl Physiol 1992, 73:S1-S3.
19. Junfeng W., Changting L., Yan L., Delong W. Effect of simulated weightlessness on alveolocapillary permeability in rats. Acad J PLA Postgrad Med Sch 2003, 24:13-15.
20. Junfeng W., Changting L., Delong W. Study on cell apoptosis in pulmonary tissue of tail-suspended rats during simulated weightlessness. Chin J Tradit West Med 2001, 2:1252-1254.
21. Junfeng W., Changting L., Delong W., Tianzhi L. The mechanism of pulmonary tissue damage in rats under simulated weightlessness condition. J Prev Med Chin PLA 2007, 25:164-166.
22. Sarkar P., Sarkar S., Ramesh V., Kim H., Barnes S., Kulkarni A., et al. Proteomic analysis of mouse hypothalamus under simulated microgravity. Neurochem Res 2008, 33:2335-2341.
23. Risso A., Tell G., Vascotto C., Costessi A., Arena S., Scaloni A., et al. Activation of human T lymphocytes under conditions similar to those that occur during exposure to microgravity: a proteomics study. Proteomics 2005, 5:1827-1837.
24. Jie C., Jin M., Zhaoping D., Lifan Z. A modified tail-suspension model or simulating long-term weightlessness. Chin J Space Sci 1993, 3:161-164.
25. Xia Q., Wang H.X., Wang J., Zhang J.Y., Liu B.Y., Li A.L., et al. Proteomic analysis of interleukin 6-induced differentiation in mouse myeloid leukemia cells. Int J Biochem Cell Biol 2005, 37:1197-1207.
26. Shellock F.G., Swan H.J.C., Rubin S.A. Early central venous pressure changes in the rat during two different levels of head down suspension. Aviat Space Environ Med 1985, 56:791-795.
27. Dunn C.D.R., Johnson P.C., Lange R.D. Regulation of hematopoiesis in rats exposed to antiorthostatic hypokinetic/hypodynamia: II. Mechanisms of the "anemia". Aviat Space Environ Med 1986, 5736-5744.
28. Overton J.M., Woodman C.R., Tipton C.M. Effects of hindlimb suspension on VO2 max and regional blood flow responses to exercise. J Appl Physiol 1989, 653-659.
29. Keely P.J., Westwick J.K., Whitehead I.P., Der C.J., PariseL V. Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K. Nature 1997, 390:632-636.
30. Vader P., van der Meel R., Symons M.H., Fens M.H., Pieters E., Wilschut K.J., et al. Examining the role of Rac1 in tumor angiogenesis and growth: a clinically relevant RNAi-mediated approach. Angiogenesis 2011, 14:457-466.
31. Bar-Sagi D., Hall A. Ras and Rho GTPases: a family reunion. Cell 2000, 103:227-238.
32. Stearns M., Tran J., Francis M., Hong Z., Sell C. Activated Ras enhances insulin-like growth factor I induction of vascular endothelial growth factor in prostate epithelial cells. Cancer Res 2005, 65:2085-2088.
33. Erlich S., Tal-Or P., Liebling R., Blum R., Karunagaran D., Kloog Y., et al. Ras inhibition results in growth arrest and death of androgen-dependent and androgen-independent prostate cancer cells. Biochem Pharmacol 2006, 72:427-436.
34. Fernandes R.S., McGowan A.J., Cotter T.G. Mutant H-ras overexpression inhibits drug and U.V. induced apoptosis. Anticancer Res 1996, 16:1691-1706.
35. Rhee S., Chae H., Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med 2005, 38:1543-1552.
36. Wood Z.A., Schröder E., Robin Harris J., Poole L.B. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci 2003, 28:32-40.
37. Shan H., Butterfield L.H., Chiu R., Kim A. Cloning and sequence analysis of candidate human natural killer-enhancing factor genes. Immunogenetics 1994, 40:129-134.
38. Anathy V., Aesif S.W., Guala A.S., Havermans M., Reynaert N.L., Ho Y.S., et al. Redox amplification of apoptosis by caspase-dependent cleavage of glutaredoxin 1 and S-glutathionylation of Fas. J Cell Biol 2009, 184:241-252.
39. Higashi-Fujime S., Nakamura A. Cell and molecular biology of the fastest myosins. Int Rev Cell Mol Biol 2009, 276:301-347.
40. Takashima S. Phosphorylation of myosin regulatory light chain by myosin light chain of kinase, and muscle contraction. Circ J 2009, 73:208-213.
41. Zolotarevsky Y., Hecht G., Koutsouris A., Gonzalez D.E., Quan C., Tom J., et al. A membrane-permeant peptide that inhibits MLC kinase restores barrier function in in vitro models of intestinal disease. Gastroenterology 2002, 23:163-172.
42. Harhaj N.S., Antonetti D.A. Regulation of tight junctions and loss of barrier function in pathophysiology. Int J Biochem Cell Biol 2004, 36:1206-1237.
43. Blikslager A.T., Moeser A.J., Gookin J.L., Jones S.L., Odle J. Restoration of barrier function in injured intestinal mucosa. Physiol Rev 2007, 87:545-564.
44. Lees-Miller J.P., Heeley D.H., Smillie L.B., Kay C.M. Isolation and characterization of an abundant and novel 22-kDa protein (SM22) from chicken gizzard smooth muscle. J Biol Chem 1987, 262:2988-2993.
45. Ming L., Shengtao L., Zhiyong L., Xiaoping L., Xiaodong Z., Zhaohui M., et al. Crystal structure of human transgelin. J Struct Biol 2008, 62:229-236.
46. Fu Y., Liu H.W., Forsythe S., Kogut P., McConville J.F., Halayko A.J., et al. Mutagenesis analysis of human SM2: characterization of actin binding. J Appl Physiol 2000, 89:1985-1990.
47. Nair R.R., Solway J., Boyd D.D. Expression cloning identifies transgelin (SM22) as a novel repressor of 92-kDa type IV collagenase (MMP-9) expression. J Biol Chem 2006, 281:26424-26436.
48. Zhang H., Tasaka S., Shiraishi Y., Fukunaga K., Yamada W., Seki H., et al. Role of soluble receptor for advanced glycation end products on endotoxin-induced lung injury. Am J Respir Crit Care Med 2008, 178:356-362.
49. Griffiths M.J., McAuley D.F. RAGE: a biomarker for acute lung injury. Thorax 2008, 63:1034-1036.
50. Pertyńska-Marczewska M., Głowacka E., Sobczak M., Cypryk K., Wilczyński J. Glycation end products, soluble receptor for advanced glycation endproducts and cytokines in diabetic and non-diabetic pregnancies. Am J Reprod Immunol 2009, 61:175-182.
51. Shaikh S., Nicholson L.F. Advanced glycation end products induce in vitro cross-linking of alpha-synuclein and accelerate the process of intracellular inclusion body formation. J Neurosci Res 2008, 86:2071-2082.
52. Gugliucci A., Bendayan M. Renal fate of circulating advanced glycated end products (AGE): evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells. Diabetologia 1996, 39:149-160.
53. Yan H.D., Li X.Z., Xie J.M., Li M. Effects of advanced glycation end products on renal fibrosis and oxidative stress in cultured NRK-49F cells. Chin Med J 2007, 120:787-793.
54. Camps M., Nichols A., Arkinstall S. Dual specificity phosphatases: a gene family for control of MAP kinase function. FASEB J 2000, 14:6-16.
55. Sparkes R.S., Sparkes M.C., Wilson M.G., Towner J.W., Benedict W., Murphree A.L., et al. Regional assignment of genes for human esterase D and retinoblastoma to chromosome band 13q14. Science 1980, 208:1042-1044.
56. Wu D., Li Y., Song G., Zhang D., Shaw N., Liu Z.J. Crystal structure of human esterase D: a potential genetic marker of retinoblastoma. FASEB J 2009, 23:1441-1446.
57. Kim S.K., Baek M.C., Kim D.H., Kim B.K., Choi E.C. Cloning and sequencing of the Klebsiella K-36 astA gene, encoding an arylsulfate sulfotransferase. Microbiol Immunol 1996, 40:531-537.
58. Beck F.K., Rosenthal T.C. Prealbumin: a marker for nutritional evaluation. Am Fam Physician 2002, 5:1575-1578.